Sort   by:  
 Page size 
UnknownRacial diversity of actionable mutations in non-small cell lung cancer.
Not available
S-EPMC4305026 | biostudies-literature
UnknownPhysical activity and quality of life in African American cancer survivors: The Detroit Research on Cancer Survivors study.
Not available
S-EPMC8293666 | biostudies-literature
UnknownGenes associated with prostate cancer are differentially expressed in African American and European American men.
Not available
S-EPMC4097306 | biostudies-literature
UnknownCOPD-dependent effects of genetic variation in key inflammation pathway genes on lung cancer risk.
Not available
S-EPMC7211135 | biostudies-literature
UnknownDesign and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial.
Not available
S-EPMC6889917 | biostudies-literature
UnknownDesign and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.
Not available
S-EPMC6888890 | biostudies-literature
UnknownFinerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis.
Not available
S-EPMC9862372 | biostudies-literature
UnknownAlcohol consumption and lung cancer risk: A pooled analysis from the International Lung Cancer Consortium and the SYNERGY study.
Not available
S-EPMC6662590 | biostudies-literature
UnknownOutcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes: A FIDELITY Subgroup Analysis.
Not available
S-EPMC10278789 | biostudies-literature
UnknownFinerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study.
Not available
S-EPMC9271031 | biostudies-literature
Sort   by:  
 Page size